Claudia M. Efstathiou

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Investigating prognostic classifications of preexisting multiple long-term conditions for health outcomes 1 year after COVID-19 hospitalization: A UK prospective observational study.

Investigating prognostic classifications of preexisting multiple long-term conditions for health outcomes 1 year after COVID-19 hospitalization: A UK prospective observational study.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: December 16, 2025

Investigating prognostic classifications of pre-existing multiple long-term conditions for health outcomes one-year after COVID-19 hospitalisation: a UK prospective observational study.

Investigating prognostic classifications of pre-existing multiple long-term conditions for health outcomes one-year after COVID-19 hospitalisation: a UK prospective observational study.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: December 16, 2025

Mucosal IL-36 is a defining feature of severe paediatric bronchiolitis.

Mucosal IL-36 is a defining feature of severe paediatric bronchiolitis.

Journal: Mucosal immunology
Published: October 07, 2025

Mucosal IL-36 is a defining feature of severe paediatric bronchiolitis.

Mucosal IL-36 is a defining feature of severe paediatric bronchiolitis.

Journal: Mucosal immunology
Published: October 07, 2025

HLA-B*15:01-positive severe COVID-19 patients lack CD8+ T cell pools with highly expanded public clonotypes.

HLA-B*15:01-positive severe COVID-19 patients lack CD8+ T cell pools with highly expanded public clonotypes.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 02, 2025

Antibody-mediated protection against respiratory syncytial virus in children.

Antibody-mediated protection against respiratory syncytial virus in children.

Journal: European respiratory review : an official journal of the European Respiratory Society
Published: May 17, 2024

Respiratory syncytial virus NS1 inhibits anti-viral Interferon-α-induced JAK/STAT signaling, by limiting the nuclear translocation of STAT1.

Respiratory syncytial virus NS1 inhibits anti-viral Interferon-α-induced JAK/STAT signaling, by limiting the nuclear translocation of STAT1.

Journal: Frontiers in immunology
Published: March 04, 2024

Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease.

Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease.

Journal: Nature immunology
Published: August 11, 2023

Long COVID: clues about causes.

Long COVID: clues about causes.

Journal: The European respiratory journal
Published: March 08, 2023

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.

Journal: EBioMedicine
Published: September 09, 2022

The interplay between the immune system and viruses.

The interplay between the immune system and viruses.

Journal: Vitamins and hormones
Published: August 23, 2021

Revisiting respiratory syncytial virus's interaction with host immunity, towards novel therapeutics.

Revisiting respiratory syncytial virus's interaction with host immunity, towards novel therapeutics.

Journal: Cellular and molecular life sciences : CMLS
Published: October 17, 2019
Showing 1-12 of 12

Last Updated: 09/26/2026